Semler Scientific (NASDAQ:SMLR) reported Q2 EPS of $0.51, $0.06 better than the analyst estimate of $0.45. Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.71 million.
Semler Scientific (NASDAQ:SMLR) reported Q2 EPS of $0.51, $0.06 better than the analyst estimate of $0.45. Revenue for the quarter came in at $14.8 million versus the consensus estimate of $14.71 million.